2022-04-29 16:00Financial Performance - The company's revenue for Q1 2022 was RMB 629,519,132.31, representing a decrease of 61.02% compared to the same period last year[4] - The net loss attributable to shareholders was RMB -396,395,486.59, a decline of 205.06% year-over-year[4] - The company reported a net profit excluding non-recurring items of RMB -429,583,325.21, a decline of 218.99% compared to the same period last year[4] - The net profit attributable to the parent company for Q1 2022 was -396,395,486.59 CNY, compared to a profit of 377,321,280.11 CNY in Q1 2021, indicating a significant decline[19] - The total comprehensive income for Q1 2022 was -471,770,135.33 CNY, compared to 379,422,645.53 CNY in Q1 2021, reflecting a substantial decrease[19] - The basic and diluted earnings per share for Q1 2022 were both -0.44 CNY, down from 0.43 CNY in Q1 2021[19] Cash Flow and Liquidity - The net cash flow from operating activities was RMB 570,432,127.10, an increase of 42.75% compared to the previous year[4] - Cash flow from operating activities for Q1 2022 was 570,432,127.10 CNY, a decrease from 399,613,641.51 CNY in Q1 2021[20] - Cash and cash equivalents increased to ¥4,259,927,063.42 in Q1 2022, up from ¥3,506,637,890.39 at the end of 2021, representing a growth of 21.5%[14] - The company’s cash and cash equivalents at the end of Q1 2022 stood at 4,258,353,489.75 CNY, up from 3,282,286,048.21 CNY at the end of Q1 2021[21] - The company received 380,000,000.00 CNY from minority shareholders in Q1 2022, marking a significant inflow compared to the previous year[20] - The cash outflow for investing activities in Q1 2022 was -175,320,677.30 CNY, an improvement from -489,544,165.73 CNY in Q1 2021[20] Research and Development - R&D expenses totaled RMB 510,912,040.65, accounting for 81.16% of revenue, which is an increase of 53.26 percentage points year-over-year[5] - R&D expenses increased to ¥510,912,040.65 in Q1 2022, up 13.3% from ¥450,649,443.76 in Q1 2021[18] Assets and Liabilities - The total assets at the end of the reporting period were RMB 10,953,222,268.79, a decrease of 0.74% from the end of the previous year[5] - Total assets as of March 31, 2022, were ¥10,953,222,268.79, slightly down from ¥11,034,911,100.95 at the end of 2021[17] - Total liabilities decreased to ¥2,651,629,271.81 in Q1 2022 from ¥2,718,536,814.27 in Q4 2021, a reduction of 2.5%[16] - The company reported a significant increase in long-term equity investments to ¥502,348,197.82 in Q1 2022, up from ¥457,791,434.27 in Q4 2021[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 33,735, with HKSCC NOMINEES LIMITED holding 24.08% of shares[9] - The number of A-share shareholders was 33,727 as of the report date[12] Sales Performance - The sales revenue from the product Tuoyi® (JS001) in Q1 2022 was RMB 110 million, showing significant growth compared to previous periods[5] - Operating costs for Q1 2022 were ¥1,012,253,166.19, down from ¥1,154,773,625.99 in Q1 2021, reflecting a reduction of 12.3%[18] Other Financial Metrics - The weighted average return on net assets was -5.10%, a decrease of 11.34 percentage points year-over-year[5] - The company experienced a significant decline in technology licensing income, which contributed to the overall revenue drop[7]